ACUTE GROWTH-HORMONE (GH) RESPONSE TO GH-RELEASING HEXAPEPTIDE IN HUMANS IS INDEPENDENT OF ENDOGENOUS GH-RELEASING HORMONE

The synthetic GH-releasing hexapeptide (GHRP: His-DTrp-Ala-Trp-DPhe-Lys-NH2) releases GH in man by an undetermined mechanism. To investigate whether acute GH response to GHRP is mediated by endogenous GHRH, we examined the effect of GHRP on GH release during pituitary desensitization to GHRH induced by short-term GHRH infusion. In five healthy men on six occasions, we infused saline (sal) or 1 mug/kg.h GHRH-44 for 6 h. After 4 h, a bolus of sal, GHRH-44 1 mug/kg body weight, or GHRP 1 mug/kg body weight was given iv. GH concentration, measured by RIA, was analyzed by mean area under the curve (AUC) of GH released over the 2 h immediately after bolus injection. lnfusion of GHRH had a biphasic effect on GH release; plasma GH increased to 12.7 +/- 3.3 mug/L within the first hour, with subsequent decrease to 2.9 +/- 0.3 mug/L during the last 2 h of infusion. GH AUC (hours 4-6 of infusion) mug/L.2 h [GRAPHICS] GH response to bolus GHRH was abolished by GHRH infusion, whereas GH response to GHRP persisted under the same conditions. Thus, we conclude that acute GH response to GHRP in humans is not mediated by endogenous GHRH.